17h
HealthDay on MSNTherapeutic Vaccine May Fight Advanced Kidney CancerA small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
1h
News Medical on MSNOpioid δ-receptor agonists show promise for treating IBS-like symptomsResearch reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...
A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...
Researchers have found that Artemisia herba-alba, a medicinal herb, contains compounds capable of fighting colorectal cancer.
41mOpinion
Sentinel & Enterprise on MSNEditorial: Psychedelics lobby turns to lawmakers’ clinically-based billsPlant-based medicine advocates haven’t given up their efforts to see that therapeutic method take root. Question 4, defeated ...
The history of therapy is difficult to quantify in that, for as long as human beings have walked the Earth, they have shared ...
A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...
20h
GlobalData on MSNFDA grants orphan drug status to Arbor Biotechnologies’ PH1The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation ...
About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...
The exploration of natural products and their structural analogues in neuropsychiatry has historically been a fertile area of research, driven by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results